Filing Details

Accession Number:
0001179110-18-014193
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-20 17:26:39
Reporting Period:
2018-12-19
Accepted Time:
2018-12-20 17:26:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Idera Pharmaceuticals Inc. IDRA Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532475 Alan Mark Goldberg C/O Idera Pharmaceuticals, Inc.
505 Eagleview Blvd., Suite 212
Exton PA 19341
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-19 10,000 $3.19 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $3.16 to $3.20 per share. The reporting person hereby undertakes, upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.